 | | 3LX | | 表記: | tridecanethial | | 組成式: | C13 H26 S | | SMILES: | S=CCCCCCCCCCCCC | | InChi: | InChI=1S/C13H26S/c1-2-3-4-5-6-7-8-9-10-11-12-13-14/h13H,2-12H2,1H3 | | 定義日: | 2014-09-20 | | 最終更新日: | 2024-09-27 | | 公開日: | 2015-03-11 | | 識別子(ID): | tridecanethial |
|
 | | 9S7 | | 表記: | 5-acetamido-2,6-anhydro-3,5,8-trideoxy-3-fluoro-D-threo-L-galacto-nononic acid | | 組成式: | C11 H18 F N O7 | | SMILES: | O=C(O)C1C(F)C(C(C(O1)C(O)CCO)NC(=O)C)O | | InChi: | InChI=1S/C11H18FNO7/c1-4(15)13-7-8(17)6(12)10(11(18)19)20-9(7)5(16)2-3-14/h5-10,14,16-17H,2-3H2,1H3,(H,13,15)(H,18,19)/t5-,6-,7-,8+,9+,10+/m1/s1 | | 別名: | 5-(acetylamino)-2,6-anhydro-3,5,8-trideoxy-3-fluoro-D-threo-L-galacto-nononic acid | | 定義日: | 2017-06-07 | | 最終更新日: | 2024-09-27 | | 公開日: | 2018-02-21 | | 識別子(ID): | 5-(acetylamino)-2,6-anhydro-3,5,8-trideoxy-3-fluoro-D-threo-L-galacto-nononic acid |
|
 | | 9SJ | | 表記: | 5-acetamido-2,6-anhydro-3,5,7-trideoxy-3-fluoro-D-threo-L-galacto-nononic acid | | 組成式: | C11 H18 F N O7 | | SMILES: | O=C(C)NC1C(O)C(F)C(OC1CC(CO)O)C(=O)O | | InChi: | InChI=1S/C11H18FNO7/c1-4(15)13-8-6(2-5(16)3-14)20-10(11(18)19)7(12)9(8)17/h5-10,14,16-17H,2-3H2,1H3,(H,13,15)(H,18,19)/t5-,6-,7+,8-,9-,10-/m0/s1 | | 別名: | 5-(acetylamino)-2,6-anhydro-3,5,7-trideoxy-3-fluoro-D-threo-L-galacto-nononic acid | | 定義日: | 2017-06-07 | | 最終更新日: | 2024-09-27 | | 公開日: | 2018-02-21 | | 識別子(ID): | 5-(acetylamino)-2,6-anhydro-3,5,7-trideoxy-3-fluoro-D-threo-L-galacto-nononic acid |
|
 | | 9SL | | 表記: | [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate | | 組成式: | C10 H17 N7 O4 | | SMILES: | C132C(CCN1C(=NC(COC(=O)N)C2NC(=N3)N)N)(O)O | | InChi: | InChI=1S/C10H17N7O4/c11-6-15-5-4(3-21-8(13)18)14-7(12)17-2-1-9(19,20)10(5,17)16-6/h4-5,19-20H,1-3H2,(H2,12,14)(H2,13,18)(H3,11,15,16)/t4-,5-,10-/m0/s1 | | 別名: | Saxitoxin | | 定義日: | 2018-07-18 | | 最終更新日: | 2024-09-27 | | 公開日: | 2018-08-08 | | 識別子(ID): | [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate |
|
 | | 9SV | | 表記: | 2-(4-methylpiperazin-1-yl)-3-(phenylsulfanyl)naphthalene-1,4-dione | | 組成式: | C21 H20 N2 O2 S | | SMILES: | C1N(CCN(C1)C2=C(C(c3ccccc3C2=O)=O)Sc4ccccc4)C | | InChi: | InChI=1S/C21H20N2O2S/c1-22-11-13-23(14-12-22)18-19(24)16-9-5-6-10-17(16)20(25)21(18)26-15-7-3-2-4-8-15/h2-10H,11-14H2,1H3 | | 別名: | BOUND FORM | | 定義日: | 2017-06-07 | | 最終更新日: | 2024-09-27 | | 公開日: | 2017-06-21 | | 識別子(ID): | 2-(4-methylpiperazin-1-yl)-3-(phenylsulfanyl)naphthalene-1,4-dione |
|
 | | 9SW | | 表記: | methoxy-[(3~{R})-3-[(2~{R})-1-methoxy-1,3-bis(oxidanylidene)butan-2-yl]pentadecyl]phosphinic acid | | 組成式: | C21 H41 O6 P | | SMILES: | CCCCCCCCCCCC[CH](CC[P](O)(=O)OC)[CH](C(C)=O)C(=O)OC | | InChi: | InChI=1S/C21H41O6P/c1-5-6-7-8-9-10-11-12-13-14-15-19(16-17-28(24,25)27-4)20(18(2)22)21(23)26-3/h19-20H,5-17H2,1-4H3,(H,24,25)/t19-,20+/m1/s1 | | 定義日: | 2017-07-09 | | 最終更新日: | 2024-09-27 | | 公開日: | 2018-01-24 | | 識別子(ID): | methoxy-[(3~{R})-3-[(2~{R})-1-methoxy-1,3-bis(oxidanylidene)butan-2-yl]pentadecyl]phosphinic acid |
|
 | | 9T1 | | 表記: | 5-acetamido-2,6-anhydro-3,5,9-trideoxy-3-fluoro-D-erythro-L-gluco-non-4-ulosonic acid | | 組成式: | C11 H16 F N O7 | | SMILES: | O=C(C)NC1C(=O)C(F)C(OC1C(C(C)O)O)C(=O)O | | InChi: | InChI=1S/C11H16FNO7/c1-3(14)7(16)10-6(13-4(2)15)8(17)5(12)9(20-10)11(18)19/h3,5-7,9-10,14,16H,1-2H3,(H,13,15)(H,18,19)/t3-,5-,6-,7-,9+,10-/m1/s1 | | 別名: | 5-(acetylamino)-2,6-anhydro-3,5,9-trideoxy-3-fluoro-D-erythro-L-gluco-non-4-ulosonic acid | | 定義日: | 2017-06-07 | | 最終更新日: | 2024-09-27 | | 公開日: | 2018-02-21 | | 識別子(ID): | 5-(acetylamino)-2,6-anhydro-3,5,9-trideoxy-3-fluoro-D-erythro-L-gluco-non-4-ulosonic acid |
|
 | | 3MY | | 表記: | 3-chloro-D-tyrosine | | 組成式: | C9 H10 Cl N O3 | | SMILES: | Clc1cc(ccc1O)CC(C(=O)O)N | | InChi: | InChI=1S/C9H10ClNO3/c10-6-3-5(1-2-8(6)12)4-7(11)9(13)14/h1-3,7,12H,4,11H2,(H,13,14)/t7-/m1/s1 | | 定義日: | 2009-03-27 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | 3-chloro-D-tyrosine |
|
 | | 9TG | | 表記: | 3-[(2R)-2-borono-2-{[(thiophen-2-yl)acetyl]amino}ethyl]benzoic acid | | 組成式: | C15 H16 B N O5 S | | SMILES: | c2c(C(=O)O)cc(CC(B(O)O)NC(=O)Cc1cccs1)cc2 | | InChi: | InChI=1S/C15H16BNO5S/c18-14(9-12-5-2-6-23-12)17-13(16(21)22)8-10-3-1-4-11(7-10)15(19)20/h1-7,13,21-22H,8-9H2,(H,17,18)(H,19,20)/t13-/m0/s1 | | 別名: | boronic acid transition state inhibitor EC04 | | 定義日: | 2017-06-07 | | 最終更新日: | 2024-09-27 | | 公開日: | 2017-11-29 | | 識別子(ID): | 3-[(2R)-2-borono-2-{[(thiophen-2-yl)acetyl]amino}ethyl]benzoic acid |
|
 | | 9TJ | | 表記: | 3-{1-[(2R)-2-borono-2-{[(thiophen-2-yl)acetyl]amino}ethyl]-1H-1,2,3-triazol-4-yl}benzoic acid | | 組成式: | C17 H17 B N4 O5 S | | SMILES: | C(B(O)O)(Cn2cc(c1cccc(c1)C(O)=O)nn2)NC(=O)Cc3sccc3 | | InChi: | InChI=1S/C17H17BN4O5S/c23-16(8-13-5-2-6-28-13)19-15(18(26)27)10-22-9-14(20-21-22)11-3-1-4-12(7-11)17(24)25/h1-7,9,15,26-27H,8,10H2,(H,19,23)(H,24,25)/t15-/m0/s1 | | 別名: | boronic acid transition state inhibitor S03043 | | 定義日: | 2017-06-07 | | 最終更新日: | 2024-09-27 | | 公開日: | 2017-11-29 | | 識別子(ID): | 3-{1-[(2R)-2-borono-2-{[(thiophen-2-yl)acetyl]amino}ethyl]-1H-1,2,3-triazol-4-yl}benzoic acid |
|
 | | 3NK | | 表記: | 1-(6-METHOXYNAPHTHALEN-2-YL)BUTANE-1,3-DIONE | | 組成式: | C15 H14 O3 | | SMILES: | COc1ccc2cc(ccc2c1)C(=O)CC(C)=O | | InChi: | InChI=1S/C15H14O3/c1-10(16)7-15(17)13-4-3-12-9-14(18-2)6-5-11(12)8-13/h3-6,8-9H,7H2,1-2H3 | | 定義日: | 2011-09-23 | | 最終更新日: | 2024-09-27 | | 公開日: | 2012-11-02 | | 識別子(ID): | 1-(6-methoxynaphthalen-2-yl)butane-1,3-dione |
|
 | | 3NP | | 表記: | 3-NITROPROPANOIC ACID | | 組成式: | C3 H5 N O4 | | SMILES: | [O-][N+](=O)CCC(=O)O | | InChi: | InChI=1S/C3H5NO4/c5-3(6)1-2-4(7)8/h1-2H2,(H,5,6) | | 定義日: | 2005-02-09 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | 3-nitropropanoic acid |
|
 | | 3NS | | 表記: | (3S)-4-hydroxy-3-{[(2S)-4-{[2-(2-methyl-1H-benzimidazol-1-yl)ethyl]amino}-2-(1-methylethyl)-4-oxobutanoyl]amino}butanoic acid | | 組成式: | C21 H30 N4 O5 | | SMILES: | O=C(O)CC(NC(=O)C(C(C)C)CC(=O)NCCn1c2ccccc2nc1C)CO | | InChi: | InChI=1S/C21H30N4O5/c1-13(2)16(21(30)24-15(12-26)10-20(28)29)11-19(27)22-8-9-25-14(3)23-17-6-4-5-7-18(17)25/h4-7,13,15-16,26H,8-12H2,1-3H3,(H,22,27)(H,24,30)(H,28,29)/t15-,16-/m0/s1 | | 定義日: | 2010-07-06 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | (3S)-4-hydroxy-3-{[(2S)-4-{[2-(2-methyl-1H-benzimidazol-1-yl)ethyl]amino}-4-oxo-2-(propan-2-yl)butanoyl]amino}butanoic acid |
|
 | | 3OH | | 表記: | 3-HYDROXY-PROPANOIC ACID | | 組成式: | C3 H6 O3 | | SMILES: | O=C(O)CCO | | InChi: | InChI=1S/C3H6O3/c4-2-1-3(5)6/h4H,1-2H2,(H,5,6) | | 定義日: | 1999-07-08 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | 3-hydroxypropanoic acid |
|
 | | 7UV | | 表記: | (3-{(E)-2-[2-chloro-4-(hydroxyboranyl)phenyl]ethenyl}phenyl)boronic acid | | 組成式: | C14 H13 B2 Cl O3 | | SMILES: | c1(BO)ccc(c(c1)Cl)[C@H]=[C@H]c2cc(ccc2)B(O)O | | InChi: | InChI=1S/C14H13B2ClO3/c17-14-9-12(15-18)7-6-11(14)5-4-10-2-1-3-13(8-10)16(19)20/h1-9,15,18-20H/b5-4+ | | 定義日: | 2016-12-06 | | 最終更新日: | 2024-09-27 | | 公開日: | 2017-09-27 | | 識別子(ID): | (3-{(E)-2-[2-chloro-4-(hydroxyboranyl)phenyl]ethenyl}phenyl)boronic acid |
|
 | | 3P7 | | 表記: | (2R)-2-[(1R)-1-{[(2R)-2-carboxy-2-(4-hydroxyphenyl)acetyl]amino}-1-methoxy-2-oxoethyl]-5-methylidene-5,6-dihydro-2H-1,3
-oxazine-4-carboxylic acid | | 組成式: | C18 H18 N2 O9 | | SMILES: | O=C(O)C(c1ccc(O)cc1)C(=O)NC(OC)(C=O)C2N=C(C(=C)CO2)C(=O)O | | InChi: | InChI=1S/C18H18N2O9/c1-9-7-29-17(19-13(9)16(26)27)18(8-21,28-2)20-14(23)12(15(24)25)10-3-5-11(22)6-4-10/h3-6,8,12,17,22H,1,7H2,2H3,(H,20,23)(H,24,25)(H,26,27)/t12-,17-,18+/m1/s1 | | 別名: | MOXALACTAM DERIVATIVE (open form) | | 定義日: | 2014-10-01 | | 最終更新日: | 2024-09-27 | | 公開日: | 2014-10-15 | | 識別子(ID): | (2R)-2-[(1R)-1-{[(2R)-2-carboxy-2-(4-hydroxyphenyl)acetyl]amino}-1-methoxy-2-oxoethyl]-5-methylidene-5,6-dihydro-2H-1,3-oxazine-4-carboxylic acid |
|
 | | 3PA | | 表記: | 3-CYCLOPENTYL-PROPIONIC ACID | | 組成式: | C8 H14 O2 | | SMILES: | O=C(O)CCC1CCCC1 | | InChi: | InChI=1S/C8H14O2/c9-8(10)6-5-7-3-1-2-4-7/h7H,1-6H2,(H,9,10) | | 定義日: | 2000-08-08 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | 3-cyclopentylpropanoic acid |
|
 | | 7V2 | | 表記: | N-[(benzyloxy)carbonyl]-L-valyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-4-methyl-L-leucinamide | | 組成式: | C27 H42 N4 O6 | | SMILES: | CC(C)C(NC(=O)OCc1ccccc1)C(=O)NC(CC(C)(C)C)C(=O)NC(CC1CCNC1=O)CO | | InChi: | InChI=1S/C27H42N4O6/c1-17(2)22(31-26(36)37-16-18-9-7-6-8-10-18)25(35)30-21(14-27(3,4)5)24(34)29-20(15-32)13-19-11-12-28-23(19)33/h6-10,17,19-22,32H,11-16H2,1-5H3,(H,28,33)(H,29,34)(H,30,35)(H,31,36)/t19-,20-,21-,22-/m0/s1 | | 定義日: | 2021-08-22 | | 最終更新日: | 2024-09-27 | | 公開日: | 2022-07-20 | | 識別子(ID): | N-[(benzyloxy)carbonyl]-L-valyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-4-methyl-L-leucinamide |
|
 | | 7V9 | | 表記: | ~{S}-[2-[3-[[(2~{S})-3,3-dimethyl-2-oxidanyl-4-phosphonooxy-butanoyl]amino]propanoylamino]ethyl] pyridine-3-carbothioate | | 組成式: | C17 H26 N3 O8 P S | | SMILES: | CC(C)(CO[P](O)(O)=O)[CH](O)C(=O)NCCC(=O)NCCSC(=O)c1cccnc1 | | InChi: | InChI=1S/C17H26N3O8PS/c1-17(2,11-28-29(25,26)27)14(22)15(23)20-7-5-13(21)19-8-9-30-16(24)12-4-3-6-18-10-12/h3-4,6,10,14,22H,5,7-9,11H2,1-2H3,(H,19,21)(H,20,23)(H2,25,26,27)/t14-/m1/s1 | | 定義日: | 2017-01-19 | | 最終更新日: | 2024-09-27 | | 公開日: | 2018-02-07 | | 識別子(ID): | ~{S}-[2-[3-[[(2~{S})-3,3-dimethyl-2-oxidanyl-4-phosphonooxy-butanoyl]amino]propanoylamino]ethyl] pyridine-3-carbothioate |
|
 | | 3PK | | 表記: | (2S)-1-(pentanoyloxy)propan-2-yl hexanoate | | 組成式: | C14 H26 O4 | | SMILES: | O=C(OC(C)COC(=O)CCCC)CCCCC | | InChi: | InChI=1S/C14H26O4/c1-4-6-8-10-14(16)18-12(3)11-17-13(15)9-7-5-2/h12H,4-11H2,1-3H3/t12-/m0/s1 | | 定義日: | 2010-11-08 | | 最終更新日: | 2024-09-27 | | 公開日: | 2013-10-16 | | 識別子(ID): | (2S)-1-(pentanoyloxy)propan-2-yl hexanoate |
|
 | | 7VB | | 表記: | N-[(benzyloxy)carbonyl]-L-valyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-4-methylidene-L-norvalinamide | | 組成式: | C26 H38 N4 O6 | | SMILES: | CC(C)C(NC(=O)OCc1ccccc1)C(=O)NC(CC(=C)C)C(=O)NC(CC1CCNC1=O)CO | | InChi: | InChI=1S/C26H38N4O6/c1-16(2)12-21(24(33)28-20(14-31)13-19-10-11-27-23(19)32)29-25(34)22(17(3)4)30-26(35)36-15-18-8-6-5-7-9-18/h5-9,17,19-22,31H,1,10-15H2,2-4H3,(H,27,32)(H,28,33)(H,29,34)(H,30,35)/t19-,20-,21-,22-/m0/s1 | | 定義日: | 2021-08-23 | | 最終更新日: | 2024-09-27 | | 公開日: | 2022-07-20 | | 識別子(ID): | N-[(benzyloxy)carbonyl]-L-valyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-4-methylidene-L-norvalinamide |
|
 | | 3PL | | 表記: | 3-PHENYLPROPANAL | | 組成式: | C9 H10 O | | SMILES: | O=CCCc1ccccc1 | | InChi: | InChI=1S/C9H10O/c10-8-4-7-9-5-2-1-3-6-9/h1-3,5-6,8H,4,7H2 | | 定義日: | 2005-01-14 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | 3-phenylpropanal |
|
 | | 7VI | | 表記: | N-[(benzyloxy)carbonyl]-L-valyl-3-cyclopropyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-alaninamide | | 組成式: | C26 H38 N4 O6 | | SMILES: | CC(C)C(NC(=O)OCc1ccccc1)C(=O)NC(CC1CC1)C(=O)NC(CC1CCNC1=O)CO | | InChi: | InChI=1S/C26H38N4O6/c1-16(2)22(30-26(35)36-15-18-6-4-3-5-7-18)25(34)29-21(12-17-8-9-17)24(33)28-20(14-31)13-19-10-11-27-23(19)32/h3-7,16-17,19-22,31H,8-15H2,1-2H3,(H,27,32)(H,28,33)(H,29,34)(H,30,35)/t19-,20-,21-,22-/m0/s1 | | 定義日: | 2021-08-23 | | 最終更新日: | 2024-09-27 | | 公開日: | 2022-07-20 | | 識別子(ID): | N-[(benzyloxy)carbonyl]-L-valyl-3-cyclopropyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-alaninamide |
|
 | | 3PX | | 表記: | (3S)-3-(propan-2-yloxy)-L-proline | | 組成式: | C8 H15 N O3 | | SMILES: | O=C(O)C1NCCC1OC(C)C | | InChi: | InChI=1S/C8H15NO3/c1-5(2)12-6-3-4-9-7(6)8(10)11/h5-7,9H,3-4H2,1-2H3,(H,10,11)/t6-,7-/m0/s1 | | 定義日: | 2011-04-26 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | (3S)-3-(propan-2-yloxy)-L-proline |
|
 | | 3PY | | 表記: | 3-HYDROXYPYRUVIC ACID | | 組成式: | C3 H4 O4 | | SMILES: | O=C(O)C(=O)CO | | InChi: | InChI=1S/C3H4O4/c4-1-2(5)3(6)7/h4H,1H2,(H,6,7) | | 定義日: | 1999-07-08 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | 3-hydroxy-2-oxopropanoic acid |
|